Abstract
Oral immunotherapy (OIT) has emerged as a therapeutic intervention for patients with persistent IgE-mediated cow's milk allergy (IgE-CMA). The long-term safety and efficacy of milk-OIT in these patients, however, requires additional investigation.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
